Current through Register Vol. 50, No. 9, September 20, 2024
Section XIII-14101 - PurposeA. The purpose of Regulation 100 is to implement Act 350 of the 2011 Regular Session of the Louisiana Legislature pertaining to the coverage of prescription drugs through a drug formulary as set forth in R.S. 22:1060.1 et seq. which provides for the continuation of drug coverage and notice to enrollees regarding drug formularies covered by a health insurance issuer as well as any modifications made thereto. The purpose of Regulation 100 is to clarify the requirements and notice forms now mandated by law.B. The purpose of the amendment to Regulation 100 is to update the Regulation to account for the notice requirements that were added to R.S. 22:1068(D)(3) and R.S. 22:1074(D)(3) by Act No. 217 of the 2021 Regular Session that a health insurance issuer must follow when modifying certain drug coverages offered in the group and individual markets.La. Admin. Code tit. 37, § XIII-14101
Promulgated by the Department of Insurance, Office of the Commissioner, LR 38:1027 (April 2012), Amended LR 451207 (9/1/2019), Repromulgated LR 451778 (12/1/2019), Amended LR 482298 (9/1/2022).AUTHORITY NOTE: Promulgated in accordance with R.S.22:11, R.S. 1068(D) and R.S. 22:1074(D).